MétaCan
Menu
Back to cohort
Record W4225826608 · doi:10.1136/jnnp-2021-328710

Development of a sensitive trial-ready poly(GP) CSF biomarker assay for <i>C9orf72</i> -associated frontotemporal dementia and amyotrophic lateral sclerosis

2022· article· en· W4225826608 on OpenAlexafffund
Katherine Wilson, Eszter Katona, Idoia Glaria, Mireia Carcolé, Imogen J. Swift, Aitana Sogorb‐Esteve, Carolin Heller, Arabella Bouzigues, Amanda Heslegrave, Ashvini Keshavan, Kathryn Knowles, Saurabh Patil, Susovan Mohapatra, Yuanjing Liu, Jaya Goyal, Raquel Sánchez‐Valle, Robert Laforce, Matthis Synofzik, James B. Rowe, Elizabeth Finger, Rik Vandenberghe, Christopher Butler, Alexander Gerhard, John C. van Swieten, Harro Seelaar, Barbara Borroni, Daniela Galimberti, Alexandre de Mendonça, Mario Masellis, Maria Carmela Tartaglia, Markus Otto, Caroline Graff, Simon Ducharme, Jonathan M. Schott, Andrea Malaspina, Henrik Zetterberg, Ramakrishna Boyanapalli, Jonathan D. Rohrer, Adrian M. Isaacs

Bibliographic record

VenueJournal of Neurology Neurosurgery & Psychiatry · 2022
Typearticle
Languageen
FieldMedicine
TopicAmyotrophic Lateral Sclerosis Research
Canadian institutionsMcGill UniversityDouglas Mental Health University InstituteMontreal Neurological Institute and HospitalUniversity of TorontoOccupational Cancer Research CentreHealth Sciences CentreSunnybrook Health Science CentreWestern UniversityUniversité Laval
FundersH2020 European Research CouncilNIHR Cambridge Biomedical Research CentreHorizon 2020 Framework ProgrammeUK Dementia Research InstituteFondazione I.R.C.C.S. Istituto Neurologico Carlo BestaUniversità degli Studi di BresciaUniversidade de LisboaUniversità degli Studi di FirenzeUniversidade de CoimbraUniversity of TorontoFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoEberhard Karls Universität TübingenUniversität UlmToronto Rehabilitation InstituteUniversity Health NetworkEuropean CommissionMotor Neurone Disease AssociationBritish Heart FoundationLudwig-Maximilians-Universität MünchenNational Institute for Health and Care ResearchBrain Research UKAlzheimer's Research TrustSorbonne UniversitéUniversità degli Studi di MilanoBarts CharityErasmus Medisch CentrumEngineering and Physical Sciences Research CouncilInstitut National de la Santé et de la Recherche MédicaleEU Joint Programme – Neurodegenerative Disease ResearchSunnybrook Research InstituteLondon School of Hygiene and Tropical MedicineKarolinska InstitutetWeston Brain InstituteAlzheimer's SocietyWellcome TrustCentre National de la Recherche ScientifiqueWolfson FoundationMedical Research CouncilDepartment of Health and Social CareMcGill UniversityFidelity Foundation
KeywordsC9orf72Amyotrophic lateral sclerosisFrontotemporal dementiaBiomarkerMedicineOncologyInternal medicineDementiaBiologyGeneticsDisease

Abstract

fetched live from OpenAlex

Objective A GGGGCC repeat expansion in the C9orf72 gene is the most common cause of genetic frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). As potential therapies targeting the repeat expansion are now entering clinical trials, sensitive biomarker assays of target engagement are urgently required. Our objective was to develop such an assay. Methods We used the single molecule array (Simoa) platform to develop an immunoassay for measuring poly(GP) dipeptide repeat proteins (DPRs) generated by the C9orf72 repeat expansion in cerebrospinal fluid (CSF) of people with C9orf72 -associated FTD/ALS. Results and conclusions We show the assay to be highly sensitive and robust, passing extensive qualification criteria including low intraplate and interplate variability, a high precision and accuracy in measuring both calibrators and samples, dilutional parallelism, tolerance to sample and standard freeze–thaw and no haemoglobin interference. We used this assay to measure poly(GP) in CSF samples collected through the Genetic FTD Initiative (N=40 C9orf72 and 15 controls). We found it had 100% specificity and 100% sensitivity and a large window for detecting target engagement, as the C9orf72 CSF sample with the lowest poly(GP) signal had eightfold higher signal than controls and on average values from C9orf72 samples were 38-fold higher than controls, which all fell below the lower limit of quantification of the assay. These data indicate that a Simoa-based poly(GP) DPR assay is suitable for use in clinical trials to determine target engagement of therapeutics aimed at reducing C9orf72 repeat-containing transcripts.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.050
GPT teacher head0.292
Teacher spread0.242 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations31
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Neurology Neurosurgery & PsychiatrySame topicAmyotrophic Lateral Sclerosis ResearchFrench-language works237,207